The largest database of trusted experimental protocols

Cmv pp65 peptide pool

Manufactured by Miltenyi Biotec

The CMV pp65 peptide pool is a collection of overlapping peptides derived from the cytomegalovirus (CMV) pp65 antigen. The pool is designed to provide a comprehensive representation of the pp65 protein sequence and can be used for the detection and analysis of CMV-specific T cell responses.

Automatically generated - may contain errors

4 protocols using cmv pp65 peptide pool

1

Multimodal PBMC Stimulation and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were stimulated with either PMA/Iono (Cell stimulation cocktail, eBioscience), plate-bound CD3/CD49d/soluble CD28 (at 10 μg/mL, 5 μg/mL, and 5 μg/mL respectively) or with peptides or their mixtures [Influenza Matrix peptide57–66 (AnaSpec, San Jose, CA), EBV BZLF-1 peptide pool, CMV pp65 peptide pool (both Miltenyi Biotec, San Diego, CA) or HIV-1 PTE Gag peptide pool43 (link) (obtained from the NIH AIDS reagent program)] for 3 hrs in the presence of brefeldin A (eBioscience). All peptides were used according to manufacturer’s instructions at approximately 1 μg/mL of each peptide; peptide mixtures were constructed as sets of 15-mers overlapped by 9 amino acids. Phenotype and cytokine production were evaluated by flow cytometry as described above. In the phospho ERK blocking experiment, MAPK inhibitor U0126 (Tocris Bioscience, Bristol, UK) was added to PBMCs for 3 h prior stimulation with PMA/Iono.
+ Open protocol
+ Expand
2

Multimodal PBMC Stimulation and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were stimulated with either PMA/Iono (Cell stimulation cocktail, eBioscience), plate-bound CD3/CD49d/soluble CD28 (at 10 μg/mL, 5 μg/mL, and 5 μg/mL respectively) or with peptides or their mixtures [Influenza Matrix peptide57–66 (AnaSpec, San Jose, CA), EBV BZLF-1 peptide pool, CMV pp65 peptide pool (both Miltenyi Biotec, San Diego, CA) or HIV-1 PTE Gag peptide pool43 (link) (obtained from the NIH AIDS reagent program)] for 3 hrs in the presence of brefeldin A (eBioscience). All peptides were used according to manufacturer’s instructions at approximately 1 μg/mL of each peptide; peptide mixtures were constructed as sets of 15-mers overlapped by 9 amino acids. Phenotype and cytokine production were evaluated by flow cytometry as described above. In the phospho ERK blocking experiment, MAPK inhibitor U0126 (Tocris Bioscience, Bristol, UK) was added to PBMCs for 3 h prior stimulation with PMA/Iono.
+ Open protocol
+ Expand
3

Cytokine Profiling of CMV-Stimulated Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cryopreserved expanded cells were stimulated with CMV pp65 peptide pool (Miltenyi) 50 ng/mL at a cell concentration of 1E+06 cells/mL in a 96-well plate. Supernatant samples were collected at 0, 6, 10, 24, and 48 h. All samples were centrifuged at 1,000 g for 15 min at 4°C. To remove aggregates or debris, samples were centrifuged again at 10,000 g for 10 min at 4°C and stored at −80°C until analysis. Samples were thawed just once and kept on ice before assay. The Bio-Plex Pro™ Human Cytokine Th1/Th2 (Bio-Rad Laboratories, Hercules, CA, USA) was used for the determination of levels of 9 cytokines: IL-2, IL-4, IL-5, IL-10, IL-12 (p70), IL-13, IFN-γ, GM-CSF, and TNF-α in a multiplex assay using a Luminex 100IS analyzer (Luminex Corp. Austin. TX, USA) according to the manufacturer's instructions. Duplicates were tested for each sample. Data analysis was performed using Bioplex Manager Software v6.1 (Bio-Rad Laboratories Inc.).
+ Open protocol
+ Expand
4

T-cell Proliferation and Cytokine Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell proliferation was measured using the carboxy fluoroscein succinimidyl ester (CFSE) dilution assay [87 (link)], following co-culture with antigen-loaded autologous monocyte-derived dendritic cells (MDDC). Briefly, monocytes isolated from PBMCs by negative selection using magnetic beads (Miltenyi Biotec) [86 (link)] were differentiated into MDDC in the presence of GM-CSF and IL-4 (20 ng/ml; R&D Systems). MDDCs were loaded with SEB (25 ng/ml; Toxin Technologies), CMV-pp65 peptide pool (1 μg/ml; Miltenyi) or Candida albicans hyphae LAM-1 [88 (link)] (25 µl protein lysate [87 (link)]) for one hour at 37 °C and cocultured with FACS-sorted CFSE-loaded T-cell subsets. MDDC:T-cell cocultures (1:4 ratio) were maintained for 5 days at 37 °C. MDDC:T-cell co-cultures were stained with CD3 (T-cell marker) and CD1c (DC marker). Proliferating T-cells were identified as cells with a CFSElowCD3+CD1c phenotype. In parallel, MDDC:T-cell co-cultures were stimulated with PMA and Ionomycin in the presence of brefeldin A and the expression of cytokines in proliferating T-cell subsets was quantified by FACS upon intracellular staining with specific anti-cytokine Abs (See table above). Intracellular expression of cytokines was quantified by FACS [87 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!